Bills · HR 6977
IN COMMITTEE· 119TH CONGRESS
House BillHR 6977Health
Better Care for PFAS Patients Act of 2026
INTRO JAN 8· LAST ACTION JAN 8
READING
3MIN
COSPONSORS
1
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because PFAS chemicals are widespread in our environment, found in drinking water, food, and various consumer products, and have been linked to serious health problems like cancer, thyroid disease, and developmental issues. Many people are unknowingly exposed, and the medical community's understanding of how to best address these health effects is constantly evolving.
If this bill becomes law, it would create a consistent and reliable process for ensuring that healthcare providers receive the most current, evidence-based guidance on how to identify, assess, and manage PFAS-related health concerns. This means patients could receive more informed diagnoses and better treatment, potentially leading to improved health outcomes. Without this bill, critical, up-to-date medical information on PFAS might remain fragmented or less accessible, making it harder for doctors to effectively respond to this growing public health challenge.
KEY PROVISIONS
4AI-extractedPROVISION 01
Requires the Agency for Toxic Substances and Disease Registry (ATSDR) to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to assess PFAS health effects and formulate clinical recommendations.
Ensures that expert, independent scientific evaluation of PFAS impacts and treatment strategies forms the basis of medical guidance.
PROVISION 02
Mandates that the initial assessment and recommendations be completed within 2 years of the agreement, with updates every 5 years or more frequently if deemed necessary.
Ensures that medical guidance remains current and responsive to new scientific understanding and emerging data about PFAS.
PROVISION 03
Requires ATSDR to issue, post on its public website, and widely disseminate up-to-date clinical guidance based on the expert assessments and recommendations.
Guarantees that expert scientific findings are translated into practical and accessible advice for healthcare professionals and public health authorities.
PROVISION 04
Requires the entity conducting the assessments to consult with PFAS-exposed communities and solicit their input on exposure, testing, and follow-up.
Incorporates real-world experiences and concerns of affected individuals directly into the scientific review and recommendation process.
SPONSORSHIP
1 + 1
D· Oregon
YRS IN OFFICE
1
BILLS LED
20
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 0 REP 1 IND 0
ACTION TIMELINE
2 EVENTSJAN 8
Introduced in House
JAN 8
Referred to the House Committee on Energy and Commerce.
BILL INFO
TypeHouse Bill
NumberHR 6977
Congress119th
StatusIn Committee
IntroducedJan 8, 2026
Last actionJan 8, 2026
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · ENERGY AND COMMERCE COMMITTEE · INTRODUCED JAN 8, 2026
House BillHR 6977Health
Better Care for PFAS Patients Act of 2026
INTRODUCED JAN 8, 2026· LAST ACTION JAN 8, 2026
PASSAGE CHANCES
—%
READING
3 min
COSPONSORS
1
COMPLEXITY
Moderate
